Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation

Adriano Venditti,Luca Maurillo,Francesco Buccisano,G. Del Poeta,C Mazzone,A. Tamburini,M. I. Del Principe,Maria Irno Consalvo,P. De Fabritiis,L Cudillo,Alessandra Picardi,A. Franchi,Francesco Lo-Coco,Sergio Amadori

Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation

2003

Adriano Venditti
Luca Maurillo
Francesco Buccisano
G. Del Poeta
C Mazzone
A. Tamburini
M. I. Del Principe
Maria Irno Consalvo
P. De Fabritiis
L Cudillo
Alessandra Picardi
A. Franchi
Francesco Lo-Coco
Sergio Amadori

Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation

Keywords:

Minimal residual disease
Cancer research
Stem cell
Myeloid leukemia
Immunology
Autologous stem-cell transplantation
Chemotherapy
Medicine
high dose chemotherapy
Surgery
Oncology
hematopoietic cell
Internal medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations